A Randomised, Double-blind Placebo-controlled Study to Assess the Safety of Four Single Ascending Doses of HF1020 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 28 Oct 2011
At a glance
- Drugs HF 1020 (Primary)
- Indications Allergic asthma; Type 1 diabetes mellitus
- Focus Adverse reactions
- 01 Sep 2011 New trial record